Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production

Diabetes

Volumn 49, Issue 7, 2000, Pages 1231-1238

  Steinberg, Helmut O ^a   Paradisi, Giancarlo ^a   Hook, Ginger ^a   Crowder, Kristin ^a   Cronin, Jessica ^a   Baron, Alain D ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Richard L Roudeboush Vet Aff M   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; ARTICLE; FATTY ACID METABOLISM; GLUCOSE TRANSPORT; HEMODYNAMIC MONITORING; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; NORMAL HUMAN; PRIORITY JOURNAL; SHEAR STRESS; VASCULAR DISEASE; VASODILATATION;

EID: 0033944950     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.7.1231     Document Type: Article

References (36)

1. Laakso M, Edelman SV, Brechtel G, Baron AD: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men. J Clin Invest 85:1844-1852, 1990
2. Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G: Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786-792, 1995
3. Hogikyan RV, Galecki AT, Pitt B, Halter JB, Greene DA, Supiano MA: Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. J Clin Endocrinol Metab 83:1946-1952, 1998
4. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Andrews JW, Hayes JR: Impaired endothelium dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771-776, 1992
5. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD: Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610, 1996
6. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000, 1989
7. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
8. Boden G: Fatty acids and insulin resistance. Diabetes Care 19:394-395, 1996
9. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA: Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 257:E49-E56, 1989
10. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259, 1999
11. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD: Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100:1230-1239, 1997
12. Lundman P, Erickson M, Schenck-Gustavson K, Karpe K, Tornvall P: Transient triglyceridemia decreases vascular reactivity in young, healthy men without factors for coronary heart disease. Circulation 96:3266-3268, 1997
13. Vollenweider L, Tappy L, Owlya R, Jequier E, Nicod P, Scherrer U: Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Diabetes 44:641-645, 1995
14. Baron AD, Steinberg H, Brechtel G, Johnson A: Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol 266:E248-E253, 1994
15. Novak M: Colorimetric ultramicro method for the determination of free fatty acids. J Lipid Res 6:431-433, 1965
16. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
17. Makimattila S, Liu ML, Vakkilainen J, Schlenzka A, Lahdenpera S, Syvanne M, Mantysaari M, Summanen P, Bergholm R, Taskinen MR, Yki-Jarvinen H: Impaired endothelium-dependent vasodilation in type 2 diabetes: relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 22:973-981, 1999
18. Laine H, Yki-Jarvinen H, Kirvela O, Tolvanen T, Raitakari M, Solin O, Haaparanta M, Knuuti J, Nuutila P: Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest 101:1156-1162, 1998
19. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511-2515, 1994
20. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J Clin Invest 94:1172-1179, 1994
21. ++-ATPase. Am J Hypertens 5:637-641, 1992
22. Piatti PM, Monti LD, Conti M, Baruffaldi L, Galli L, Phan CV, Guazzini B, Pontiroli AE, Pozza G: Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 45:316-321, 1996
23. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM: Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 26:764-770, 1995
24. 2 causes endothelial barrier dysfunction without disrupting the arginine-nitric oxide pathway. Am J Physiol 274:L508-L516, 1998
25. Davda RK, Chandler LJ, Guzman NJ: Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase. Eur J Pharmacol 266:237-244, 1994
26. Morrison KJ, Pollock D: Impairment of relaxations to acetylcholine and nitric oxide by a phorbol ester in rat isolated aorta. Br J Pharmacol 101:432-436, 1990
27. 2+ and phospholipids. J Biol Chem 261:15424-15429, 1986
28. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104:447-457, 1999
29. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601, 1999
30. Dimmeler S, Fleming I, Fissthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605, 1999
31. Zeug G, Quon MJ: Insulin stimulated production of nitric oxide is inhibited by Wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 98:894-898, 1996
32. Laine H, Knuuti MJ, Ruotsalainen U, Utriainen T, Oikonen V, Raitakari M, Luotolahti M, Kirvela O, Vicini P, Cobelli C, Nuutila P, Yki-Jarvinen H: Preserved relative dispersion but blunted stimulation of mean flow, absolute dispersion, and blood volume by insulin in skeletal muscle of patients with essential hypertension. Circulation 97:2146-2153, 1998
33. Panza JA, Quyyumi A, Brush JE, Epstein SE: Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22-27, 1990
34. Paradisi G, Steinberg HO, Shepard M, Baron AD: Polycystic syndrome is associated with endothelial dysfunction (Abstract). Diabetes 47 (Suppl. 1): 309A, 1998
35. Lloyd-Jones DM, Bloch KD: The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 47:365-375, 1996
36. Cannon RO III: Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 44:1809-1819, 1998